|
1
|
Filipowicz W, Bhattacharyya SN and
Sonenberg N: Mechanisms of post-transcriptional regulation by
microRNAs: Are the answers in sight? Nat Rev Genet. 9:102–114.
2008. View
Article : Google Scholar : PubMed/NCBI
|
|
2
|
Shi M, Liu D, Duan H, Shen B and Guo N:
Metastasis-related miRNAs, active players in breast cancer invasion
and metastasis. Cancer Metastasis Rev. 29:785–799. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Meng F, Henson R, Wehbe-Janek H, Smith H,
Ueno Y and Patel T: The MicroRNA let-7a modulates
interleukin-6-dependent STAT-3 survival signaling in malignant
human cholangiocytes. J Biol Chem. 282:8256–8264. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Fassina A, Cappellesso R, Simonato F, Siri
M, Ventura L, Tosato F, Busund LT, Pelizzo MR and Fassan M: A
4-MicroRNA signature can discriminate primary lymphomas from
anaplastic carcinomas in thyroid cytology smears. Cancer
Cytopathol. 122:274–281. 2014. View Article : Google Scholar
|
|
5
|
Wang Q, Huang Z, Guo W, Ni S, Xiao X, Wang
L, Huang D, Tan C, Xu Q, Zha R, et al: MicroRNA-202-3p inhibits
cell proliferation by targeting ADP-ribosylation factor-like 5A in
human colorectal carcinoma. Clin Cancer Res. 20:1146–1157. 2014.
View Article : Google Scholar
|
|
6
|
Nohata N, Sone Y, Hanazawa T, Fuse M,
Kikkawa N, Yoshino H, Chiyomaru T, Kawakami K, Enokida H, Nakagawa
M, et al: miR-1 as a tumor suppressive microRNA targeting TAGLN2 in
head and neck squamous cell carcinoma. Oncotarget. 2:29–42. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Huang S, Chen Y, Wu W, Ouyang N, Chen J,
Li H, Liu X, Su F, Lin L and Yao Y: miR-150 promotes human breast
cancer growth and malignant behavior by targeting the pro-apoptotic
purinergic P2X7 receptor. PLoS One. 8:e807072013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Gerin I, Clerbaux LA, Haumont O, Lanthier
N, Das AK, Burant CF, Leclercq IA, MacDougald OA and Bommer GT:
Expression of miR-33 from an SREBP2 intron inhibits cholesterol
export and fatty acid oxidation. J Biol Chem. 285:33652–33661.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Marquart TJ, Allen RM, Ory DS and Baldán
A: miR-33 links SREBP-2 induction to repression of sterol
transporters. Proc Natl Acad Sci USA. 107:12228–12232. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Najafi-Shoushtari SH, Kristo F, Li Y,
Shioda T, Cohen DE, Gerszten RE and Näär AM: MicroRNA-33 and the
SREBP host genes cooperate to control cholesterol homeostasis.
Science. 328:1566–1569. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Rayner KJ, Suárez Y, Dávalos A, Parathath
S, Fitzgerald ML, Tamehiro N, Fisher EA, Moore KJ and
Fernández-Hernando C: MiR-33 contributes to the regulation of
cholesterol homeostasis. Science. 328:1570–1573. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Dávalos A, Goedeke L, Smibert P, Ramírez
CM, Warrier NP, Andreo U, Cirera-Salinas D, Rayner K, Suresh U,
Pastor-Pareja JC, et al: miR-33a/b contribute to the regulation of
fatty acid metabolism and insulin signaling. Proc Natl Acad Sci
USA. 108:9232–9237. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wijesekara N, Zhang LH, Kang MH, Abraham
T, Bhattacharjee A, Warnock GL, Verchere CB and Hayden MR: miR-33a
modulates ABCA1 expression, cholesterol accumulation and insulin
secretion in pancreatic islets. Diabetes. 61:653–658. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ramírez CM, Goedeke L, Rotllan N, Yoon JH,
Cirera-Salinas D, Mattison JA, Suárez Y, de Cabo R, Gorospe M and
Fernández-Hernando C: MicroRNA 33 regulates glucose metabolism. Mol
Cell Biol. 33:2891–2902. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Goedeke L, Vales-Lara FM, Fenstermaker M,
Cirera-Salinas D, Chamorro-Jorganes A, Ramírez CM, Mattison JA, de
Cabo R, Suárez Y and Fernández-Hernando C: A regulatory role for
microRNA 33* in controlling lipid metabolism gene
expression. Mol Cell Biol. 33:2339–2352. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Rice SJ, Lai SC, Wood LW, Helsley KR,
Runkle EA, Winslow MM and Mu D: MicroRNA-33a mediates the
regulation of high mobility group AT-hook 2 gene (HMGA2) by thyroid
transcription factor 1 (TTF-1/NKX2-1). J Biol Chem.
288:16348–16360. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Fang Y, Feng Y, Wu T, Srinivas S, Yang W,
Fan J, Yang C and Wang S: Aflatoxin B1 negatively regulates
Wnt/ß-catenin signaling pathway through activating miR-33a. PLoS
One. 8:e730042013. View Article : Google Scholar
|
|
18
|
Yu XF, Zou J, Bao ZJ and Dong J: miR-93
suppresses proliferation and colony formation of human colon cancer
stem cells. World J Gastroenterol. 17:4711–4717. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhou Y, Huang Z, Wu S, Zang X, Liu M and
Shi J: miR-33a is up-regulated in chemoresistant osteosarcoma and
promotes osteosarcoma cell resistance to cisplatin by
down-regulating TWIST. J Exp Clin Cancer Res. 33(12)2014.
View Article : Google Scholar
|
|
20
|
Zhang T, Han G, Wang Y, Chen K and Sun Y:
MicroRNA expression profiles in supraglottic carcinoma. Oncol Rep.
31:2029–2034. 2014.PubMed/NCBI
|
|
21
|
Li X, Luo F, Li Q, Xu M, Feng D, Zhang G
and Wu W: Identification of new aberrantly expressed miRNAs in
intestinal-type gastric cancer and its clinical significance. Oncol
Rep. 26:1431–1439. 2011.PubMed/NCBI
|
|
22
|
Kuo PL, Liao SH, Hung JY, Huang MS and Hsu
YL: MicroRNA-33a functions as a bone metastasis suppressor in lung
cancer by targeting parathyroid hormone related protein. Biochim
Biophys Acta. 1830:3756–3766. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Herrera-Merchan A, Cerrato C, Luengo G,
Dominguez O, Piris MA, Serrano M and Gonzalez S: miR-33-mediated
down-regulation of p53 controls hematopoietic stem cell
self-renewal. Cell Cycle. 9:3277–3285. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Cirera-Salinas D, Pauta M, Allen RM,
Salerno AG, Ramírez CM, Chamorro-Jorganes A, Wanschel AC, Lasuncion
MA, Morales-Ruiz M, Suarez Y, et al: MiR-33 regulates cell
proliferation and cell cycle progression. Cell Cycle. 11:922–933.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Thomas M, Lange-Grünweller K, Weirauch U,
Gutsch D, Aigner A, Grünweller A and Hartmann R: The proto-oncogene
Pim-1 is a target of miR-33a. Oncogene. 31:918–928. 2012.
View Article : Google Scholar
|
|
26
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kang YK, Kang WK, Shin DB, Chen J, Xiong
J, Wang J, Lichinitser M, Guan Z, Khasanov R, Zheng L, et al:
Capecitabine/cisplatin versus 5-fluorouracil/cisplatin as
first-line therapy in patients with advanced gastric cancer: A
randomised phase III noninferiority trial. Ann Oncol. 20:666–673.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ajani JA, Rodriguez W, Bodoky G,
Moiseyenko V, Lichinitser M, Gorbunova V, Vynnychenko I, Garin A,
Lang I and Falcon S: Multicenter phase III comparison of
cisplatin/S-1 with cisplatin/infusional fluorouracil in advanced
gastric or gastro-esophageal adenocarcinoma study: The FLAGS trial.
J Clin Oncol. 28:1547–1553. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ohtsu A, Shah MA, Van Cutsem E, Rha SY,
Sawaki A, Park SR, Lim HY, Yamada Y, Wu J, Langer B, et al:
Bevacizumab in combination with chemotherapy as first-line therapy
in advanced gastric cancer: A randomized, double-blind,
placebo-controlled phase III study. J Clin Oncol. 29:3968–3976.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Guo W, Dong Z, Guo Y, Chen Z, Kuang G and
Yang Z: Methylation-mediated repression of GADD45A and GADD45G
expression in gastric cardia adenocarcinoma. Int J Cancer.
133:2043–2053. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Kong D, Zheng T, Zhang M, Wang D, Du S, Li
X, Fang J and Cao X: Static mechanical stress induces apoptosis in
rat endplate chondrocytes through MAPK and mitochondria-dependent
caspase activation signaling pathways. PLoS One. 8:e694032013.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Tang H, Deng M, Tang Y and Xie X, Guo J,
Kong Y, Ye F, Su Q and Xie X: miR-200b and miR-200c as prognostic
factors and mediators of gastric cancer cell progression. Clin
Cancer Res. 19:5602–5612. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Zhou X, Sang M, Liu W, Gao W, Xing E, Lü
W, Xu Y, Fan X, Jing S and Shan B: LMO4 inhibits p53-mediated
proliferative inhibition of breast cancer cells through interacting
p53. Life Sci. 91:358–363. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Nurse P: Checkpoint pathways come of age.
Cell. 91:865–867. 1997. View Article : Google Scholar
|
|
35
|
Rivadeneira DB, Mayhew CN, Thangavel C,
Sotillo E, Reed CA, Graña X and Knudsen ES: Proliferative
suppression by CDK4/6 inhibition: Complex function of the
retinoblastoma pathway in liver tissue and hepatoma cells.
Gastroenterology. 138:1920–1930. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Bachmann M, Hennemann H, Xing PX, Hoffmann
I and Möröy T: The oncogenic serine/threonine kinase Pim-1
phosphorylates and inhibits the activity of Cdc25C-associated
kinase 1 (C-TAK1): A novel role for Pim-1 at the G2/M cell cycle
checkpoint. J Biol Chem. 279:48319–48328. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Cen B, Mahajan S, Wang W and Kraft AS:
Elevation of receptor tyrosine kinases by small molecule AKT
inhibitors in prostate cancer is mediated by Pim-1. Cancer Res.
73:3402–3411. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Vogelstein B, Lane D and Levine AJ:
Surfing the p53 network. Nature. 408:307–310. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Waldman T, Kinzler KW and Vogelstein B:
p21 is necessary for the p53-mediated G1 arrest in human cancer
cells. Cancer Res. 55:5187–5190. 1995.PubMed/NCBI
|
|
40
|
Baselga-Escudero L, Arola-Arnal A,
Pascual-Serrano A, Ribas-Latre A, Casanova E, Salvadó MJ, Arola L
and Blade C: Chronic administration of proanthocyanidins or
docosahexaenoic acid reverses the increase of miR-33a and miR-122
in dyslipidemic obese rats. PLoS One. 8:e698172013. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Wang JM, Zhou JJ, Zheng Q, Gan H and Wang
H: Dialysis method alters the expression of microRNA-33a and its
target genes ABCA1, ABCG1 in THP-1 macrophages. Ther Apher Dial.
18:44–50. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Li T, Francl JM, Boehme S and Chiang JY:
Regulation of cholesterol and bile acid homeostasis by the
cholesterol 7α-hydroxylase/steroid response element-binding protein
2/microRNA-33a axis in mice. Hepatology. 58:1111–1121. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Zhang F, Taipale M, Heiskanen A and Laiho
M: Ectopic expression of Cdk6 circumvents transforming growth
factor-beta mediated growth inhibition. Oncogene. 20:5888–5896.
2001. View Article : Google Scholar : PubMed/NCBI
|
